HOME >> MEDICINE >> NEWS
UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a UCLA research team a five-year, $9 million contract to fund a multicenter study investigating antibiotic treatments for MRSA, a staph infection seen increasingly in communities across the nation that is resistant to antibiotics most commonly used to treat skin infections.

The study, to be led by co-principal investigators Dr. David A. Talan and Dr. Gregory J. Moran, both of Olive ViewUCLA Medical Center and the David Geffen School of Medicine at UCLA, will explore whether various off-patent antibiotics for the treatment of uncomplicated skin and soft tissue infections may be effective in treating MRSA, or methicillin-resistant Staphylococcus aureus. Off-patent medications are those whose patents have expired, allowing any manufacturer to produce them.

The emergence of the new, potentially more infectious and virulent strain of S. aureus in the community, referred to as community-associated or CAMRSA, has caused serious outbreaks of disease over the past few years, said Talan, a professor of medicine at the Geffen School of Medicine and chief of emergency medicine and professor of infectious diseases at Olive ViewUCLA. We are hopeful to be able to identify the most effective antibiotic treatment for these infections.

Last year, the research team reported in The New England Journal of Medicine that CA-MRSA had become the most common cause of skin and soft tissue infections among patients presenting to a geographically diverse group of 11 emergency departments across the nation. Researchers tested MRSA resistance to antibiotics in a test tube and found that in 57 percent of cases, doctors had prescribed an antibiotic to which the bacteria were resistant. Finding certain antibiotics ineffective against MRSA in a laboratory setting, however, does not necessarily mean they will fail in patients, who have the help of thei
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
9-Aug-2007


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Penn researchers discover novel pathway for increasing good cholesterol
3. Theory of facial aging gets a facelift from UT Southwestern researchers
4. UIC researchers to develop new drugs to fight bioterrorism
5. UQ researchers discover some of the oldest forms of life
6. U of M researchers discover new method to combat HIV
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Physician-researchers often less successful in obtaining NIH funding
10. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
11. Cedars-Sinai researchers present new endocrine findings at 2 international conferences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2019)... (PRWEB) , ... December 05, 2019 , ... ... with milestones ranging from launching exceptional products that help people embrace, achieve, and ... world. , “We’ve never been more committed to our mission of impacting world ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 ... cities offer them as public transit options. The article highlighted the life-changing or life-ending ... confined to a bed to a rider fatality after an incident with a vehicle. ...
(Date:12/4/2019)... ... 04, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... a trusted advisor to the U.S. Department of Health and Human Services (HHS), announced ... the 2019 WEDI Winter Conference in Arlington, Va. on Wednesday, December 4. , “The ...
(Date:12/4/2019)... ... December 04, 2019 , ... While the holidays are a time for ... said Texas A&M AgriLife Extension Service specialists. , “There are many ... benefit your overall wellness,” said Joyce Cavanagh, AgriLife Extension specialist in family economics, College ...
(Date:12/4/2019)... YORK (PRWEB) , ... December 04, 2019 , ... ... Phase I study of AZD4041 for treating tobacco use and dependence. The study ... a central nervous system (CNS) penetrant antagonist of orexin-1 (hypocretin-1) receptors that is ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... Kindred ... expansion in services. While Kindred Nutrition and Wellness will continue to focus ... now happy to offer Individual and Family Therapy and Yoga. , Kindred Nutrition ...
(Date:12/5/2019)... ... , ... Intelligent.com, a trusted resource for online degree rankings ... for 2020. The comprehensive research guide is based on an assessment of 67 ... curriculum quality, graduation rate, reputation, and post-graduate employment. , The 2020 rankings ...
(Date:12/4/2019)... ST. LOUIS (PRWEB) , ... ... ... healthcare industry leader in delivering solutions designed for improved financial, operational and ... Officer, has earned the Fellow designation from the American College of Healthcare ...
Breaking Medicine Technology:
Cached News: